These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 28004475)
41. Differential binding affinity of tau repeat region R2 with neuronal-specific β-tubulin isotypes. Bhandare VV; Kumbhar BV; Kunwar A Sci Rep; 2019 Jul; 9(1):10795. PubMed ID: 31346240 [TBL] [Abstract][Full Text] [Related]
42. Safranal as a novel anti-tubulin binding agent with potential use in cancer therapy: An in vitro study. Naghshineh A; Dadras A; Ghalandari B; Riazi GH; Modaresi SM; Afrasiabi A; Aslani MK Chem Biol Interact; 2015 Aug; 238():151-60. PubMed ID: 26102007 [TBL] [Abstract][Full Text] [Related]
43. Mechanism of action of ixabepilone and its interactions with the βIII-tubulin isotype. Lopus M; Smiyun G; Miller H; Oroudjev E; Wilson L; Jordan MA Cancer Chemother Pharmacol; 2015 Nov; 76(5):1013-24. PubMed ID: 26416565 [TBL] [Abstract][Full Text] [Related]
44. Characterisation of benzimidazole binding with recombinant tubulin from Giardia duodenalis, Encephalitozoon intestinalis, and Cryptosporidium parvum. MacDonald LM; Armson A; Thompson AR; Reynoldson JA Mol Biochem Parasitol; 2004 Nov; 138(1):89-96. PubMed ID: 15500920 [TBL] [Abstract][Full Text] [Related]
45. Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery. Wang Y; Zhang H; Gigant B; Yu Y; Wu Y; Chen X; Lai Q; Yang Z; Chen Q; Yang J FEBS J; 2016 Jan; 283(1):102-11. PubMed ID: 26462166 [TBL] [Abstract][Full Text] [Related]
46. Discovery of benzimidazole-2-amide BNZ-111 as new tubulin inhibitor. Jang J; Koh B; Lee K Bioorg Med Chem Lett; 2024 Nov; 113():129953. PubMed ID: 39270806 [TBL] [Abstract][Full Text] [Related]
47. Structure of a benzylidene derivative of 9(10H)-anthracenone in complex with tubulin provides a rationale for drug design. Cheng J; Wu Y; Wang Y; Wang C; Wang Y; Wu C; Zeng S; Yu Y; Chen Q Biochem Biophys Res Commun; 2018 Jan; 495(1):185-188. PubMed ID: 29102632 [TBL] [Abstract][Full Text] [Related]
48. Computational design and biological testing of highly cytotoxic colchicine ring A modifications. Torin Huzil J; Winter P; Johnson L; Weis AL; Bakos T; Banerjee A; Luduena RF; Damaraju S; Tuszynski JA Chem Biol Drug Des; 2010 Jun; 75(6):541-50. PubMed ID: 20408852 [TBL] [Abstract][Full Text] [Related]
50. The Unique Binding Mode of Laulimalide to Two Tubulin Protofilaments. Churchill CD; Klobukowski M; Tuszynski JA Chem Biol Drug Des; 2015 Aug; 86(2):190-9. PubMed ID: 25376845 [TBL] [Abstract][Full Text] [Related]
51. Theoretical and experimental study of polycyclic aromatic compounds as β-tubulin inhibitors. Olazarán FE; García-Pérez CA; Bandyopadhyay D; Balderas-Rentería I; Reyes-Figueroa AD; Henschke L; Rivera G J Mol Model; 2017 Mar; 23(3):85. PubMed ID: 28214932 [TBL] [Abstract][Full Text] [Related]
52. A Computational Analysis of Indomethacin Derivative as Tubulin Inhibitor: Insights into Development of Chemotherapeutic Agents. Costa KM; Alves CN; Silva JR; Lameira J Comb Chem High Throughput Screen; 2016; 19(6):431-6. PubMed ID: 27141989 [TBL] [Abstract][Full Text] [Related]
53. Detection of human betaV-tubulin expression in epithelial cancer cell lines by tubulin proteomics. Verdier-Pinard P; Shahabi S; Wang F; Burd B; Xiao H; Goldberg GL; Orr GA; Horwitz SB Biochemistry; 2005 Dec; 44(48):15858-70. PubMed ID: 16313188 [TBL] [Abstract][Full Text] [Related]
54. A comparative study based on docking and molecular dynamics simulations over HDAC-tubulin dual inhibitors. Hassanzadeh M; Bagherzadeh K; Amanlou M J Mol Graph Model; 2016 Nov; 70():170-180. PubMed ID: 27750186 [TBL] [Abstract][Full Text] [Related]
55. Design, synthesis and biological evaluation of (E)-3-(3,4-dihydroxyphenyl)acrylylpiperazine derivatives as a new class of tubulin polymerization inhibitors. Yin Y; Qiao F; Jiang LY; Wang SF; Sha S; Wu X; Lv PC; Zhu HL Bioorg Med Chem; 2014 Aug; 22(15):4285-92. PubMed ID: 24916028 [TBL] [Abstract][Full Text] [Related]
56. The structured core of human β tubulin confers isotype-specific polymerization properties. Pamula MC; Ti SC; Kapoor TM J Cell Biol; 2016 May; 213(4):425-33. PubMed ID: 27185835 [TBL] [Abstract][Full Text] [Related]
57. Rational design of biaryl pharmacophore inserted noscapine derivatives as potent tubulin binding anticancer agents. Santoshi S; Manchukonda NK; Suri C; Sharma M; Sridhar B; Joseph S; Lopus M; Kantevari S; Baitharu I; Naik PK J Comput Aided Mol Des; 2015 Mar; 29(3):249-70. PubMed ID: 25481458 [TBL] [Abstract][Full Text] [Related]
58. Effects of eribulin on microtubule binding and dynamic instability are strengthened in the absence of the βIII tubulin isotype. Wilson L; Lopus M; Miller HP; Azarenko O; Riffle S; Smith JA; Jordan MA Biochemistry; 2015 Oct; 54(42):6482-9. PubMed ID: 26435331 [TBL] [Abstract][Full Text] [Related]
59. Sulfamic acid promoted one-pot synthesis of phenanthrene fused-dihydrodibenzo-quinolinones: Anticancer activity, tubulin polymerization inhibition and apoptosis inducing studies. Kumar NP; Thatikonda S; Tokala R; Kumari SS; Lakshmi UJ; Godugu C; Shankaraiah N; Kamal A Bioorg Med Chem; 2018 May; 26(8):1996-2008. PubMed ID: 29525336 [TBL] [Abstract][Full Text] [Related]
60. Stabilization of microtubules by taxane diterpenoids: insight from docking and MD simulations. Yadava U; Gupta H; Roychoudhury M J Biol Phys; 2015 Mar; 41(2):117-33. PubMed ID: 25542396 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]